ID
ABBV icon

Integral Derivatives’s AbbVie ABBV Stock Holding History

Integral Derivatives’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.66M Sell
17,500
-16,200
-48% -$1.78M 0.04% 149
2017
Q4 		$3.26M Sell
33,700
-28,500
-46% -$2.69M 0.06% 199
2017
Q3 		$5.53M Buy
62,200
+18,100
+41% +$1.38M 0.1% 124
2017
Q2 		$3.2M Sell
44,100
-9,000
-17% -$605K 0.07% 193
2017
Q1 		$3.46M Sell
53,100
-40,800
-43% -$2.57M 0.06% 192
2016
Q4 		$5.88M Buy
93,900
+44,000
+88% +$2.69M 0.11% 119
2016
Q3 		$3.15M Sell
49,900
-400
-0.8% -$25.9K 0.07% 180
2016
Q2 		$3.11M Buy
50,300
+15,200
+43% +$926K 0.08% 153
2016
Q1 		$2M Buy
35,100
+15,300
+77% +$853K 0.07% 222
2015
Q4 		$1.17M Sell
19,800
-27,700
-58% -$1.6M 0.03% 408
2015
Q3 		$2.58M Sell
47,500
-88,100
-65% -$5.73M 0.07% 239
2015
Q2 		$9.11M Buy
135,600
+94,800
+232% +$6.19M 0.25% 68
2015
Q1 		$2.39M Sell
40,800
-9,800
-19% -$592K 0.05% 248
2014
Q4 		$3.31M Buy
50,600
+38,200
+308% +$2.41M 0.06% 282
2014
Q3 		$716K Buy
+12,400
New +$688K 0.01% 841
2014
Q2 		– Sell
-12,300
Closed -$632K – 1313
2014
Q1 		$632K Sell
12,300
-57,300
-82% -$2.9M 0.01% 815
2013
Q4 		$3.68M Buy
+69,600
New +$3.42M 0.05% 302

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Integral Derivatives's ABBV Position: Q4 2017 in Review

Integral Derivatives sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 28,024 shares — an estimated $2.64M sold.

Integral Derivatives first reported a position in ABBV in Q4 2013 and held it in 7 quarters. The position peaked at $2.49M in Q3 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Integral Derivatives reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 28,024 AbbVie shares in Q4 2017, an estimated $2.64M.
  • Integral Derivatives first reported a position in AbbVie in Q4 2013 and held it in 7 quarters.
  • Integral Derivatives's AbbVie position peaked at $2.49M in Q3 2017.
  • 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.